AKT1 and hepatocellular carcinoma: TWIST1, a transcription factor encoded by an oncogene that is a target of STAT3, AKT, and Wnt/β-catenin pathways, down-regulates E-cadherin and has been found to be overexpressed in sorafenib-refractory HCC patients [180].